Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Gene therapy: cursed or inching towards credibility?

Nature Biotechnology volume 23, pages 519–521 (2005)Cite this article

Can gene therapy ever live down its setbacks and live up to its initial promise? A chastened but determined group of pioneers believes it can, and they are pointing to a new generation of products to back up that claim.

This, plus the latest round of interruptions of some gene therapy trials, less than a year after a high profile French trial was resumed (Box 1), has put this once promising field back on the hot seat, just when researchers and companies felt they were finally making some progress. Will this latest round of negative publicity put gene therapy back in the doldrums or can an approval, believed by some to be coming in the next 2–3 years, finally bring some commercial success to the sector?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Boston, Massachusetts

    Malorye A. Branca

Authors
  1. Malorye A. Branca
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

China approves first gene therapy

Gene-therapy trials to restart following cancer risk review

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Branca, M. Gene therapy: cursed or inching towards credibility?. Nat Biotechnol 23, 519–521 (2005). https://doi.org/10.1038/nbt0505-519

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0505-519

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing